Clinical Trials Logo

Clinical Trial Summary

This study is being done to look at the cardiovascular response, if any, to intake of commercially available energy drink. We hypothesize that energy drink consumption compared to a control drink in healthy adults alters the cardiovascular hemodynamic system.The focus of this study is to elucidate the physiological/cardiovascular response to an energy drink consumption as compared to a control drink both at rest and during stressful conditions in healthy adults.


Clinical Trial Description

The study will collect data to determine the hemodynamic changes (magnitude of heart rate and blood pressure response) in healthy adults after consumption of an energy drink and compare these responses to those after a control drink. Study will be performed at a hospital Clinical Research Unit on two separate days; minimum 24 hours and maximum 1 month apart. Participants will be fasting 4 hours prior to the study and will be asked to abstain from caffeine and alcohol for at least 24 hours prior to initiation of this study. Baseline measurements will be obtained during and after 10 minutes of rest. After the end of baseline recordings, the subjects will be given up to 500 ml (1 can, approximately 16 fluid ounces) of caffeinated energy drink or a control drink, based on randomization. They will have 30 minutes to drink it. The second set of measurements will be obtained after an energy drink or control drink intake, using exactly the same protocol as at baseline. The second study visit, participant will receive the alternate intervention. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01940822
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date July 2013
Completion date November 30, 2013

See also
  Status Clinical Trial Phase
Completed NCT04585568 - Validation of Ballistocardiographic Biosensors and Other Hemodynamic Measures for Healthy Subjects
Not yet recruiting NCT02202239 - Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients Phase 4
Terminated NCT01116973 - Reliability of Central Venous Pressure Measurements N/A
Recruiting NCT05752409 - Comparison of Esketamine-Propofol and Fentanyl-Propofol N/A
Completed NCT04595591 - Observation of Propofol Titration at Different Speeds N/A
Not yet recruiting NCT03729817 - REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis N/A
Completed NCT01974557 - The Effect of Age on the Hemodynamic Response During Rest and Exercise in Healthy Humans N/A
Completed NCT00620386 - Endotracheal Intubation Using Bonfils Fibrescope Without Neuromuscular Blockade Phase 2/Phase 3
Recruiting NCT06082856 - Evaluation of the Hemodynamic Effect of Dexmedetomidine in Scheduled Outpatient Surgery N/A
Recruiting NCT04665817 - Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) Study
Recruiting NCT03684291 - Hemodynamic Effects of Ventilation Modes
Recruiting NCT04291196 - Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT N/A
Terminated NCT02495662 - The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation Phase 2
Completed NCT01559285 - Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters Phase 4
Completed NCT04131699 - Electrical Velocimetry (ICON Cardiometry ) Assessment of Hemodynamic Changes During Pediatric Thoracoscopic Surgery
Completed NCT05145114 - Hemodynamic Repercussions in Different Therapeutic Positions in Premature Newborn N/A
Completed NCT04419662 - Evaluation of Patients After Cardiac Surgery: Novel Ultrasound Parameters for Quantification of Renal Perfusion & Analysis of Phenylephrines' Effect on Invasive Haemodynamics and Echocardiographic Measures Phase 4
Completed NCT02902068 - Hemodynamic Monitoring in Women Throughout Cesarean Sections
Recruiting NCT00730899 - Association Study of Gene Polymorphisms With Cardiac Performance N/A
Recruiting NCT03855579 - Levosimendan Versus Milrinone in Off Pump CABG Surgery Phase 4